REBLOZYL 25 MG POLVO PARA SOLUCION INYECTABLE
REBLOZYL 25 MG POLVO PARA SOLUCION INYECTABLE
Commercialized
Register Number
1201452001
Prescription Type
Uso Hospitalario
Authorization Date
Aug 17, 2020
Dosage Form
POLVO PARA SOLUCIÓN INYECTABLE
Route: VÍA SUBCUTÁNEA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1201452001
EMA Approved
Yes
Drug Classification
✗
Generic
No
✓
Orphan
Yes
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
LUSPATERCEPTActive
Quantity: 25 mg
Name: LUSPATERCEPT
ATC CLASSIFICATION (3)
B03X
B03XA
B03XA06